VANCOUVER, British Columbia, Oct. 05, 2022  — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and functional mushrooms, is pleased to announce that its wholly-owned subsidiary, Pure Extracts Manufacturing Corp., has received a purchase order (PO) from the Ontario Cannabis Store (OCS) for its new, cured resin, 1 g vape carts. This Pure PullsTM branded product called Durga Mata Cured Resin will be available in October for purchase through licensed retailers throughout the province of Ontario, and through the OCS’ online store.

Cured resin is a cannabis concentrate derived from dried and cured cannabis plant material. The drying and curing process removes moisture from the buds and improves the flavour and aroma of the final product. The cannabis plant material then undergoes an extraction process to produce a cured resin vape oil.

The specialized extraction techniques used to create Pure Pulls Durga Mata Cured Resin retains all the natural terpenes and the nice earthy flavour to ensure a smooth, enjoyable vaping experience every time.

Pure Extracts’ CEO, Ben Nikolaevsky, remarked, “We are excited about receiving a PO for our newest product category – cured resins. And it’s especially gratifying to have received this PO from the OCS, in the largest and most competitive provincial cannabis market in Canada. This marks another successful milestone in the expansion of our line of branded products.”

About Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)
Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act on September 25, 2020, and its Sales Amendment on July 19, 2021. The Company’s stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020.